Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30074980HIVENSG00000147432.7protein_codingCHRNB3NoNo1142Q05901
TVIS30068873HIVENSG00000147432.7protein_codingCHRNB3NoNo1142Q05901
TVIS20063274HPVENSG00000147432.7protein_codingCHRNB3NoNo1142Q05901
TVIS20035045HPVENSG00000147432.7protein_codingCHRNB3NoNo1142Q05901
TVIS20031849HPVENSG00000147432.7protein_codingCHRNB3NoNo1142Q05901
TCGA Plot Options
Drug Information
GeneCHRNB3
DrugBank IDDB00184
Drug NameNicotine
Target IDBE0003588
UniProt IDQ05901
Regulation Typeagonist
PubMed IDs19560048; 11006350; 20400469; 20081230
CitationsMansvelder HD, Mertz M, Role LW: Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol. 2009 Jun;20(4):432-40. doi: 10.1016/j.semcdb.2009.01.007. Epub 2009 Jan 22.@@Narahashi T, Fenster CP, Quick MW, Lester RA, Marszalec W, Aistrup GL, Sattelle DB, Martin BR, Levin ED: Symposium overview: mechanism of action of nicotine on neuronal acetylcholine receptors, from molecule to behavior. Toxicol Sci. 2000 Oct;57(2):193-202.@@Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA, Damaj MI: Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther. 2010 Jul;334(1):137-46. doi: 10.1124/jpet.110.165738. Epub 2010 Apr 16.@@Zaniewska M, Przegalinski E, Filip M: Nicotine dependence - human and animal studies, current pharmacotherapies and future perspectives. Pharmacol Rep. 2009 Nov-Dec;61(6):957-65.
GroupsApproved
Direct ClassificationPyrrolidinylpyridines
SMILESCN1CCC[C@H]1C1=CN=CC=C1
PathwaysNicotine Action Pathway; Nicotine Metabolism Pathway
PharmGKBPA450626
ChEMBLCHEMBL3